ARCHIVES

Bristol-Myers Squibb Board Removes CEO Peter Dolan Over Plavix Deal. Two Republican Senators Say They Will Place Holds On Confirmation of Andrew von Eschenbach as FDA Commissioner. Craig Thompson Named Director of Abramson Cancer Center.

This article is from The Cancer Letter archive.

Vol. 32 No. 32 | September 15, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: Ford Named Acting Deputy Director, DCPC; Foundation Leads Oncology Administrators

June 3, 1994

News Analysis: Industry’s Accelerated Recovery Initiative May Push Manufacturers Toward Collusion

October 5, 2012

Cancer Pain Treatment Guide Published By NCCN, ACS

April 27, 2001

Treatment IND or GM-CSF Is Approved

October 5, 1990

Cancer Education: NCI Offers Training In Epidemiology And Genetics

April 17, 1998

In Brief: Congress Working On Interim Financing Measure to Fund Agencies, Including NCI, Through Election

September 26, 1980